Showing results (1891-1900 of 2,261) with videos related to

Sort By:
Pageof 227
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|March 26, 2009
[Who are the recipients of labile blood products? A multicenter nation-wide study--a "donation day." Blood banks, health facilities]J-F Quaranta, F Berthier, R Courbil, et al.
Science (New York, N.Y.)|June 29, 2019
Generation of extreme-ultraviolet beams with time-varying orbital angular momentumLaura Rego, Kevin M Dorney, Nathan J Brooks, et al.
Immuno-Oncology Technology|August 26, 2024
Integrated noninvasive diagnostics for prediction of survival in immunotherapyM Yeghaian, Z Bodalal, T M Tareco Bucho, et al.
JNCI Cancer Spectrum|April 2, 2024
Association of breast cancer with quantitative mammographic density measures for women receiving contrast-enhanced mammographyGordon P Watt, Krishna N Keshavamurthy, Tuong L Nguyen, et al.
Medical Physics|September 4, 2023
Observer preference of artificial intelligence-generated versus clinical prostate contours for ultrasound-based high dose rate brachytherapyMartin T King, Christopher E Kehayias, Tafadzwa Chaunzwa, et al.
BMJ Open|December 28, 2023
Healthcare resource utilisation and costs of hospitalisation and primary care among adults with COVID-19 in England: a population-based cohort studyJingyan Yang, Kathleen Michelle Andersen, Kiran K Rai, et al.
Biomedical Journal|June 10, 2026
PRMT5-mediated methylation of LKB1 controls PD-L1 expression in NSCLCYi-Cheng Shen, Khuong T L Nguyen, Bo-Wei Wang, et al.
Journal of the National Cancer Institute|July 4, 2023
Leveraging national and global political determinants of health to promote equity in cancer careEdward Christopher Dee, Michelle Ann B Eala, Janine Patricia G Robredo, et al.
European Urology|December 18, 2018
Androgen Deprivation Therapy and Overall Survival for Gleason 8 Versus Gleason 9-10 Prostate CancerDavid D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.
Brachytherapy|August 17, 2016
Factors associated with the omission of androgen deprivation therapy in radiation-managed high-risk prostate cancerYu-Wei Chen, Vinayak Muralidhar, Brandon A Mahal, et al.
Pageof 227